Understand how Metrics provide the foundation for business intelligence for clinical trials, measuring success or failure.
Immuno-oncology is a unique approach to cancer treatment that leverages the body’s immune system to help fight cancer. In recent years, immune checkpoint inhibitors have changed the landscape of immunotherapy, and emerging therapies such as chimeric antigen receptor T-cells (CAR-T), dendritic cell vaccines and bi-specific T-cell engager (BiTE) antibodies are pushing the envelope even further.
As companies recognize that RBM extends beyond just on-site monitoring to all types of data monitoring, your data managers, who ultimately are the steward of data quality and data integrity in a trial, are critical to the process and cannot be left out of the conversations.
This article reviews three strategies that will help sponsors and CROs cut the time and cost of their trials while improving respiratory data quality.
Genomic- based biomarkers are powerful tools used to assess tumor mutational burden, production of novel or neo- antigens and hallmarks of genomic instability, which may be useful as measures of response or resistance to immune therapies.
To enable the completion of clinical trials as safely, efficiently and quickly as possible, PerkinElmer Informatics’ clinical solutions streamline clinical trial data visualization and analysis with real-time access to clinical data in all phases of clinical development.
Learn how PerkinElmer’s clinical solutions give clinical operations organizations the unprecedented ability to reduce the time, cost and risk of running clinical trials while accelerating the time to market for products across the entire portfolio of clinical candidates.
Achieve clinical trial operations excellence using this an innovative solution that gives clinical operations organizations the unprecedented ability to reduce the time, cost, and risk of running clinical trials while accelerating time to market for products across the entire portfolio of clinical candidates.
Logistics can be one of the most complex aspects of successful clinical trials because samples shipped from study sites for testing at a central laboratory must be maintained within a very limited temperature range. Cold chain or refrigerated logistics, where temperature is controlled in the shipping environment, often brings added challenges and expense. LabConnect provides validated cold-chain solutions, however controlled ambient shipping solutions are becoming more important in cases where whole blood samples are required by the testing laboratories. This is seen most readily in PBMC and other analyses where high cellular viability and yields are critical.